Amgen Announces Voting Results of Annual Meeting of Stockholders Read more about Amgen Announces Voting Results of Annual Meeting of Stockholders
Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio Read more about Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio
Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide Search For Champions In The Fight Against Cancer Read more about Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide Search For Champions In The Fight Against Cancer
Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society Read more about Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society
Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference Read more about Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference
Amgen Announces FDA Advisory Committee Meeting To Review Repatha™ (Evolocumab) As A Treatment For High Cholesterol Read more about Amgen Announces FDA Advisory Committee Meeting To Review Repatha™ (Evolocumab) As A Treatment For High Cholesterol
Amgen To Discuss Details Of The Biologics License Application For Talimogene Laherparepvec For Patients With Metastatic Melanoma Read more about Amgen To Discuss Details Of The Biologics License Application For Talimogene Laherparepvec For Patients With Metastatic Melanoma
Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 Read more about Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48
Amgen Announces Webcast Of 2015 First Quarter Financial Results Read more about Amgen Announces Webcast Of 2015 First Quarter Financial Results
FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure Read more about FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure
